A5053811885- SARS-CoV-2 and COVID-19 Research
- Peripheral Neuropathies and Disorders
- Multiple Sclerosis Research Studies
- LGBTQ Health, Identity, and Policy
- Retinal and Optic Conditions
- Ocular Diseases and Behçet’s Syndrome
- Metabolism and Genetic Disorders
- Monoclonal and Polyclonal Antibodies Research
- Cancer Immunotherapy and Biomarkers
- Rheumatoid Arthritis Research and Therapies
- Immunotherapy and Immune Responses
- Multiple Myeloma Research and Treatments
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Cerebral Venous Sinus Thrombosis
- Immunodeficiency and Autoimmune Disorders
- Neurogenetic and Muscular Disorders Research
Indiana University Bloomington
2022-2024
Methodist Hospital
2024
Methodist Hospital
2020-2023
University of Chicago
2018-2019
Chicago Neuropsychology Group
2019
Cedars-Sinai Medical Center
1988
University of California, Los Angeles
1988
John F. Kennedy Center for the Performing Arts
1988
Kennedy Memorial Hospital
1988
Los Angeles Medical Center
1988
B-cell depleting agents are FDA approved for the treatment of RRMS (ocrelizumab (OCR) and ofatumumab (OFA)) PPMS (OCR). In case OCR, prior studies have raised concerns about patients' ability to form antibodies in response various antigens, especially SARS-CoV-2. addition, emerging data shown an attenuated humoral vaccines against The objective this study is determine whether b-cell depleters or sphingosine 1-phosphate (S1P) modulators attenuate antibody SARS-CoV-2 patients with MS as...
Multiple sclerosis (MS) research has largely overlooked the experiences of LGBTQ+ community, leaving significant gaps in understanding and addressing their unique health equity challenges. Despite widespread recognition disparities, particularly neurology, at intersection sexual orientation, gender identity, MS remains limited. individuals encounter systemic barriers such as discrimination lack culturally competent care, exacerbating disparities management outcomes. Existing studies are...
In general, individuals who are lesbian, gay, bisexual, transgender, queer or questioning, plus other identities (LGBTQ+) living with multiple sclerosis (MS) have less favorable healthcare experiences and poorer overall health than cisgendered heterosexual individuals. They may experience further challenges in addition to managing their MS, including psychological emotional problems, an increased risk of comorbid diseases substance abuse. Transgender specifically face additional unique...
The most common ocular complication of herpes simplex virus (HSV) is acute retinal necrosis. We present a rare case patient with HSV-2 meningoencephalitis that developed severe vision-threatening optic neuritis. was treated steroids and IVIG, which allowed rapid improvement in her vision.
May 5, 2019April 9, 2019Free AccessHerpes Simplex Virus (HSV)-2 Meningoencephalitis-associated Bilateral Optic Neuritis Successfully Treated with Steroids and Intravenous Immunoglobulin (P1.9-017)Faten El Ammar, William Conte, Asadolah Movahedan, Hassan Shah, Jeffrey Nichols, Adil JavedAuthors Info & AffiliationsApril 2019 issue92 (15_supplement)https://doi.org/10.1212/WNL.92.15_supplement.P1.9-017 Letters to the Editor